Akcea Therapeutics Inc (AKCA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2019 | 12-2018 | 09-2018 | 06-2018 | 03-2018 | |
| Sales | 163,816 | 10,197 | 19,241 | 18,321 | 17,108 |
| Cost of Goods | 2,444 | 2,789 | 8,944 | N/A | 0 |
| Gross Profit | 161,372 | 7,408 | 10,297 | 18,321 | 17,108 |
| Operating Expenses | 135,609 | 80,255 | 76,249 | 81,744 | 47,435 |
| Operating Income | 26,207 | -72,058 | -65,008 | -63,423 | -30,327 |
| Other Income | 1,112 | 1,501 | 1,650 | 1,591 | 700 |
| Pre-tax Income | 27,319 | -70,557 | -63,358 | -61,832 | -29,627 |
| Income Tax | 132 | N/A | 233 | 214 | 0 |
| Net Income Continuous | 27,187 | -70,557 | -63,591 | -62,046 | -29,627 |
| Net Income | $27,187 | $-70,557 | $-63,591 | $-62,046 | $-29,627 |
| EPS Basic Total Ops | 0.30 | -0.89 | -0.73 | -0.72 | -0.44 |
| EPS Basic Continuous Ops | 0.30 | -0.85 | -0.73 | -0.75 | -0.44 |
| EPS Diluted Total Ops | 0.29 | -0.76 | -0.73 | -0.85 | -0.44 |
| EPS Diluted Continuous Ops | 0.29 | -0.85 | -0.73 | -0.75 | -0.44 |
| EPS Diluted Before Non-Recurring Items | 0.34 | -0.79 | N/A | N/A | N/A |
| EBITDA(a) | $27,961 | $-70,025 | $-64,219 | $-63,297 | $-30,121 |